Artificial intelligence in Parkinson's disease: Early detection and diagnostic advancements

被引:6
|
作者
Reddy, Aananya [1 ,2 ]
Reddy, Ruhananhad P. [1 ,2 ]
Roghani, Aryan Kia [1 ,3 ]
Garcia, Ricardo Isaiah [1 ]
Khemka, Sachi [1 ]
Pattoor, Vasanthkumar [1 ,5 ]
Jacob, Michael [1 ,4 ]
Reddy, P. Hemachandra [1 ,6 ,7 ,8 ,9 ]
Sehar, Ujala [1 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA
[2] Lubbock High Sch, Lubbock, TX 79401 USA
[3] Frenship High Sch, Lubbock, TX 79382 USA
[4] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA
[5] Univ S Florida, Tampa, FL 33620 USA
[6] Texas Tech Univ, Coll Human Med, Hlth Sci Ctr, Nutr Sci Dept, Lubbock, TX 79430 USA
[7] Texas Tech Univ, Hlth Sci Ctr, Publ Hlth Dept, Grad Sch Biomed Sci, Lubbock, TX 79430 USA
[8] Texas Tech Univ, Hlth Sci Ctr, Sch Hlth Profess, Dept pf Speech Language & Hearing Serv, Lubbock, TX 79430 USA
[9] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA
基金
美国国家卫生研究院;
关键词
Parkinson's disease; Early detectable biomarkers; Therapeutic strategies; Artificial intelligence; Machine learning tools; SOCIOECONOMIC-STATUS; ETHNIC VARIATION; BIOMARKERS; PROGRESSION; POPULATION; PREVALENCE; CONSENT; IMPACT;
D O I
10.1016/j.arr.2024.102410
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Parkinson's disease (PD) is the second most common neurodegenerative disorder, globally affecting men and women at an exponentially growing rate, with currently no cure. Disease progression starts when dopaminergic neurons begin to die. In PD, the loss of neurotransmitter, dopamine is responsible for the overall communication of neural cells throughout the body. Clinical symptoms of PD are slowness of movement, involuntary muscular contractions, speech & writing changes, lessened automatic movement, and chronic tremors in the body. PD occurs in both familial and sporadic forms and modifiable and non-modifiable risk factors and socioeconomic conditions cause PD. Early detectable diagnostics and treatments have been developed in the last several decades. However, we still do not have precise early detectable biomarkers and therapeutic agents/drugs that prevent and/or delay the disease process. Recently, artificial intelligence (AI) science and machine learning tools have been promising in identifying early detectable markers with a greater rate of accuracy compared to past forms of treatment and diagnostic processes. Artificial intelligence refers to the intelligence exhibited by machines or software, distinct from the intelligence observed in humans that is based on neural networks in a form and can be used to diagnose the longevity and disease severity of disease. The term Machine Learning or Neural Networks is a blanket term used to identify an emerging technology that is created to work in the way of a "human brain" using many intertwined neurons to achieve the same level of raw intelligence as that of a brain. These processes have been used for neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, to assess the severity of the patient's condition. In the current article, we discuss the prevalence and incidence of PD, and currently available diagnostic biomarkers and therapeutic strategies. We also highlighted
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Early detection of Parkinson's disease in ambulatory conditions
    Matmurodov, Rustambek
    Daminova, Hilola
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [42] Early detection of Parkinson's disease - Implications for treatment
    DiPaola, R
    Uitti, RJ
    DRUGS & AGING, 1996, 9 (03) : 159 - 168
  • [43] Artificial intelligence-based clustering and characterization of Parkinson's disease trajectories
    Birkenbihl, Colin
    Ahmad, Ashar
    Massat, Nathalie J.
    Raschka, Tamara
    Avbersek, Andreja
    Downey, Patrick
    Armstrong, Martin
    Froehlich, Holger
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [44] Explainable artificial intelligence for searching frequency characteristics in Parkinson’s disease tremor
    Rui En Lee
    Ping Yi Chan
    Scientific Reports, 13
  • [45] A novel artificial intelligence protocol to investigate potential leads for Parkinson's disease
    Chen, Zhi-Dong
    Zhao, Lu
    Chen, Hsin-Yi
    Gong, Jia-Ning
    Chen, Xu
    Chen, Calvin Yu-Chian
    RSC ADVANCES, 2020, 10 (39) : 22939 - 22958
  • [46] Management of Parkinson's Disease Dysarthria: Can Artificial Intelligence Provide the Solution?
    Kumar, Raj
    Tripathy, Manoj
    Kumar, Niraj
    Anand, Radhey Shyam
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2022, 25 (05) : 810 - 816
  • [47] Explainable artificial intelligence for searching frequency characteristics in Parkinson's disease tremor
    Lee, Rui En
    Chan, Ping Yi
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [48] Artificial intelligence for assisting diagnostics and assessment of Parkinson's disease-A review
    Belic, Minja
    Bobic, Vladislava
    Badza, Milica
    Solaja, Nikola
    Duric-Jovicic, Milica
    Kostic, Vladimir S.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2019, 184
  • [49] Avoiding Misdiagnosis of Parkinson's Disease With the Use of Wearable Sensors and Artificial Intelligence
    Talitckii, Aleksandr
    Kovalenko, Ekaterina
    Anikina, Anna
    Zimniakova, Olga
    Semenov, Maksim
    Bril, Ekaterina
    Shcherbak, Aleksei
    Dylov, Dmitry V.
    Somov, Andrey
    IEEE SENSORS JOURNAL, 2021, 21 (03) : 3738 - 3747
  • [50] Remote Evaluation of Parkinson's Disease Using a Conventional Webcam and Artificial Intelligence
    Monje, Mariana H. G.
    Dominguez, Sergio
    Vera-Olmos, Javier
    Antonini, Angelo
    Mestre, Tiago A.
    Malpica, Norberto
    Sanchez-Ferro, Alvaro
    FRONTIERS IN NEUROLOGY, 2021, 12